This program is funded by an independent grant from Pfizer Global Medical Grants. This online education program has been designed solely for healthcare professionals globally. The content is not available for healthcare professionals in the United States or Canada.
Join global leaders in the fight against antibiotic resistance—Professor Murat Akova, Professor Karen Burns, and Professor Matteo Bassetti—for this free online teaching session tackling the growing threat of global antibiotic resistance. This session is focussed on Metallo-β-Lactamases (MBLs) and is designed for healthcare professionals who want to understand how MBL-producing bacteria are driving global antibiotic resistance. The session will give strategies on strengthening infection control, and improving diagnostic capabilities to prevent antibiotic treatment failures.
With a live Q&A featuring our expert panel, attendees will gain critical insights to better understand the role of MBLs in antibiotic resistance and fortify infection prevention measures, all in support of the global effort to curb antibiotic resistance.
- 1.5 AMA PRA Category 1 Credits™ are available for this activity.
Improve Early Detection:
Learn to recognize the clinical signs and symptoms of infections caused by MBL-producing bacteria and differentiate them from other bacterial infections. Understand the key risk factors and patient history elements that can signal a higher likelihood of these infections, helping you make informed decisions in clinical practice.
Develop Effective Antimicrobial Therapy Plans:
Learn to design antimicrobial therapy regimens that take into account local resistance patterns and the risk of MBL production. Adjust treatment plans based on laboratory results, ensuring therapies are tailored to the specific needs of patients with MBL-producing bacterial infections.
Prevention & Infection Control:
Discover the critical infection control practices and isolation procedures needed when MBL-producing bacteria are suspected or diagnosed. Understand the role healthcare professionals play in preventing the spread of these infections in hospital environments, and learn effective strategies for educating your team about the importance of these precautions.
Faculty
Professor Karen Burns
Dr. Karen Burns is a Consultant Clinical Microbiologist at Beaumont Hospital and an Honorary Senior Lecturer at the Royal College of Surgeons in Ireland (RCSI). She actively contributes to Ireland’s Health Protection Surveillance Centre (HPSC) and has chaired the RCSI Hospitals Group Antimicrobial Stewardship Committee since 2012, where she leads initiatives in antimicrobial stewardship and guideline development. Her expertise spans antimicrobial resistance (AMR), Clostridium difficile infections, healthcare-associated infections (HCAI), influenza, and antimicrobial usage, while also managing a busy outpatient parenteral antimicrobial therapy (OPAT) program. Dr. Burns is a member of Ireland’s National Taskforce and Clinical Advisory Group on HCAI and AMR, and serves as the National Focal Point to the European Centre for Disease Prevention and Control (ECDC).
Professor Murat Akova
Professor Murat Akova graduated from Istanbul University Medical School and completed his residency in internal medicine and infectious diseases at Hacettepe University School of Medicine, where he is now a faculty member. He studied medical microbiology at London Hospital Medical College in the UK, earning a Diploma in Clinical Microbiology, and was a postdoctoral fellow at Tufts University School of Medicine, USA. Active in the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) since 2007, he served as its President (2014-2016) and currently holds the role of Past President. His research focuses on infections in immunocompromised patients and antimicrobial resistance.
Professor Matteo Bassetti
Professor Matteo Bassetti is Head of the Infectious Diseases Clinic at Policlinico San Martino University Hospital and a Full Professor of Infectious Diseases at the University of Genoa, Italy. He completed his medical training at the University of Genoa and an Infectious Diseases fellowship at Yale University School of Medicine, USA. He currently serves as President of the Italian Society of Anti-Infective Therapy (SITA) and is a key member of Italy's national committee on antimicrobial resistance. Professor Bassetti is also active in international societies, with research interests in antibiotic therapy, antimicrobial resistance, fungal infections, and infections in immunocompromised patients.
Unapproved and/or off-label use disclosure
Current Concepts Institute/MedAll requires CE faculty to disclose to the participants:
1. When products or procedures being discussed are off-label, unlabelled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and
2. Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.
Disclosures
Below is a listing of all individuals who are involved in the planning and implementation of this accredited continuing education activity. All relevant financial relationships listed for these individuals have been mitigated.
Karen Burns & Murat Akova have no relevant financial relationships with ineligible companies to disclose and no unapproved product related discussions to disclose. Matteo Bassetti has received fees for being on Advisory Board, Speaker Activities, and Research Funds for MSD, Pfizer, Shionogi, Mundipharma Angelini, Cidara, Gilead, Menarini. He has no unapproved product related discussions to disclose.
Current Concepts Institute/MedAll staff and the planners and reviewers of this educational activity have no relevant financial or non-financial interests to disclose.
Accreditation statement
AMA PRA Category 1 Credits™ are available for this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Current Concepts Institute and MedAll Education. Current Concepts Institute is accredited by the ACCME to provide continuing medical education for physicians.
Current Concepts Institute designates this online activity a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
This continuing education activity is active starting 20th November 2024 and will expire on 20th November 2025. Estimated time to complete this activity: 1.5 hours.